Evidence map›Paper›PMID 27593927›Full record

ArticleOncogene2017

Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer.

J Izrailit, A Jaiswal, W Zheng, M F Moran, M Reedijk

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Deubiquitylating Enzymes in Cancer and Immunity.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Roles of Notch Signaling in the Tumor Microenvironment.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

J IzrailitCampbell Family Institute for Cancer Research, Ontario Cancer Institute, Toronto, ON, Canada.
A JaiswalCampbell Family Institute for Cancer Research, Ontario Cancer Institute, Toronto, ON, Canada.
W ZhengCampbell Family Institute for Cancer Research, Ontario Cancer Institute, Toronto, ON, Canada.
M F MoranProgram in Molecular Structure and Function, The Hospital for Sick Children, Toronto, ON, Canada.
M ReedijkCampbell Family Institute for Cancer Research, Ontario Cancer Institute, Toronto, ON, Canada.
Princess Margaret Cancer Centre · CAHospital for Sick Children · CAOntario Institute for Cancer Research · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Expression of the Notch ligand JAG1 and Notch pathway activation promote poor prognosis, basal-like breast cancer. We have recently shown that the pseudokinase Tribbles homolog 3 (TRB3) regulates JAG1 expression in this malignancy. TRB3 is a stress and metabolic sensor, and here we show that nutrient deprivation or endoplasmic reticulum stress markedly upregulate TRB3, which serves as a scaffold for the deubiquitinase USP9x. USP9x in turn stimulates JAG1 activity through two mechanisms: (1) through TRB3 deubiquitination and stabilization, and (2) through deubiquitination and activation of Mind Bomb 1, an E3 ligase required for JAG1 ubiquitination-mediated endocytosis and Notch activation. These USP9x activities are confined to the signal-sending cell of a cell pair undergoing Notch signaling. We demonstrate that USP9x is required for TRB3 upregulation and Notch activation in response to cellular stress in basal-like breast cancer cells. These data suggest that TRB3 functions as a sensor of tumor microenvironmental stress and together with USP9x induces the cell survival and tumor-promoting activities of Notch. These findings identify a novel mechanism by which cancer cells survive in their hostile environment and provide potential therapeutic targets in breast cancer.

Indexed as

Endoplasmic Reticulum StressGene Expression Regulation, NeoplasticApoptosisBasal Cell CarcinomaBreast NeoplasmsCell Cycle ProteinsCell ProliferationFemaleHumansProtein BindingProtein Serine-Threonine KinasesReceptor, Notch1Repressor ProteinsSignal TransductionTumor Cells, CulturedUbiquitinationCell Cycle ProteinsNOTCH1 protein, humanProtein Serine-Threonine KinasesReceptor, Notch1Repressor ProteinsTRIB3 protein, humanUbiquitin ThiolesteraseUSP9X protein, human

Identifiers

PMID27593927
OpenAlexW2512462528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.